The 2nd International Electronic Conference on Clinical Medicine
The 2nd International Electronic Conference on Clinical Medicine
Chronic Diseases - Current State and Future Trends
Part of the International Electronic Conference on Clinical Medicine series
Event's Timezone: Central European TimeEpidemiology, Immunology, Mental Health, Oncology, Hematology, Dermatology, Gastroenterology and Hepatopancreatobiliary Medicine, AI and telemedicine, Cardiology
Thank you for attending ECCM 2024!
Click HERE for abstract book.
Click HERE for poster gallery.
The Best Oral Presentation Awards and Best Poster Awards are under deliberation and the winners will be announced on the website as soon as possible.
Welcome from the Chairs
Dear Colleagues,
We are pleased to announce the 2nd International Electronic Conference on Clinical Medicine: Chronic Diseases - Current State and Future Trends (ECCM 2024), which will take place online from 13 to 15 November 2024.
This conference will present the latest studies in various fields of clinical medicine. The goal is to show the current state, challenges, opportunities, and future trends.
All clinical medicine-related scientists, researchers, and individuals are welcome to join this event and share their findings pertaining to the following general and related themes, including, but not limited to, the following:
- AI and Telemedicine;
- Cardiology;
- Clinical Psychology;
- Dermatology;
- Endocrinology and Metabolism;
- Epidemiology and Public Health;
- Gastroenterology and Hepatopancreatobiliary Medicine;
- Hematology;
- Infectious Diseases;
- Nephrology and Urology;
- Neurology and Stroke Neurology;
- Nuclear Medicine and Radiology;
- Obstetrics and Gynecology;
- Oncology;
- Ophthalmology;
- Orthopedics;
- Otolaryngology;
- Pharmacology;
- Psychiatry;
- Pulmonology;
- Stomatology.
All submitted abstracts will be reviewed by the conference committee. Following the conference, authors are welcome to submit a proceedings paper, where the publication fee will be waived. Selected contributions will be invited for submission to the journal Journal of Clinical Medicine (ISSN: 2077-0383; Impact Factor: 3.0; which ranks it 58/325 and rises from Q2 to Q1 in the category "Medicine, General & Internal"; its CiteScore 2023 is 5.7, ranking 80/636 (Q1) in "General Medicine"), with a 20% discount on the publication fee.
We look forward to you joining us at this exciting event.
Conference Chairs:
Prof. Dr. Emmanuel Andrès
Internal Medicine Department, University Hospital Strasbourg, France
Prof. Dr. Kent Doi
Department of Acute Care Medicine, University of Tokyo, Japan
Follow the conference organizer on Social Media
DAY 1 Program
DAY 1
|
CET (Central European Time) |
Speaker |
Title |
|
8:30–8:40 |
Welcome from the session chair— |
|
| 8:40-9:10 |
Prof. Dr. Jesús San Miguel Izquierdo |
The Dream to cure Myeloma |
|
9:10-9:25 |
Blanca Rodríguez Díaz |
Using an electronic tool for hand hygiene auditing: improving data quality to lead to a better understanding of improvement measures
|
|
9:25-9:40 |
Krzysztof Kanecki |
The effect of the COVID-19 pandemic on influenza-related hospitalization and in-hospital fatality in Poland: A nationwide register-based study |
|
9:40-09:55 |
Katarzyna Lewtak |
Meeting the health needs of people fleeing Ukraine: Evidence from the Polish Nationwide General Hospital Morbidity Study, 2022–2023 |
|
09:55-10:10 |
Evangelos Sdogkos Selected Speaker |
Mandatory Rules as a Public Health Measure: A Study on Cardiac Patients With Recent Acute Coronary Syndrome |
|
CET (Central European Time) |
Speaker |
Title |
|
13:00-13:10 |
Welcome from the session chair— |
|
| 13:10-13:30 |
Prof. Nadav Davidovitch |
From epidemiology to policy: Vaccinations and inequalities as a case study
|
|
13:30-13:45 |
Alisa Pautova |
Aromatic microbial metabolites in the cerebrospinal fluid determined by gas chromatography–mass spectrometry as promising markers of secondary bacterial meningitis
|
|
13:45-14:00 |
Ekaterina Sorokina |
Application of bacteriophages in clinical practice |
|
14:00-14:15 |
Martyna Dąbrowska |
Hospitalizations of patients with atrial fibrillation (AF) in Poland: a nationwide study based on over one million AF hospitalizations in 2017-2021 |
|
14:15-14:30 |
Georgia Petra |
Surgical Site Infections After Major Abdominal Surgery in Greece: Results of a Nationwide Multicentre Study |
|
14:30-14:45 |
Renata Borys |
Effect of health education on rehabilitation outcomes in patients hospitalized for SARS-CoV-2 virus infection |
|
14:45-15:00 |
Rabbani Daoud |
Occupational Interdigital Pilonidal Sinus among Hairdressers and Barbers in Bahrain: A Cross-Sectional Study |
DAY 2 Program
DAY 2
Session S6. Mental Health
Session S8. Dermatology
Session S2. Gastroenterology & Hepatopancreatobiliary Medicine
|
CET (Central European Time) |
Speaker |
Title |
|
13:00-13:10 |
Welcome from the Session Chair (Session 8) — |
|
| 13:10-13:40 |
Assoc. Prof. Marie Loh |
Epigenome-wide association study of skin physiology measures in a multi-ethnic Asian population |
|
13:40-14:10 |
Dr. Gudula Kirtschig |
An up-date of Lichen sclerosus
|
|
14:10-14:25 |
Sara Goncalves |
Prevalence and Impact of Skin Disorders in Palliative Care: A Systematic Review |
|
14:25-14:40 |
Lyudmyla Susla Selected Speaker |
Recent Advancements in 3D Bioprinting for Pediatric Burn Treatment |
|
14:40-14:50 |
Welcome from the Session Chair (Session 2) |
|
|
14:50-15:10 |
Prof. Dr. Andrew Day Invited Speaker |
Inflammatory Bowel Disease Down-Under: Updates on IBD Epidemiology in New Zealand |
|
15:10-15:30 |
Davide Ribaldone Invited Speaker |
Concomitant Immune-Mediated Inflammatory Diseases |
|
15:30-15:45 |
Giorgios Giannos |
Safety, feasibility and preliminary results of a multicenter randomized trial comparing fat-free versus balanced (WHO) diet in gallstone disease (The Rationale Diet for Gallstones (RADIGAL) study) |
|
15:45-16:00 |
Jordyn Yokoyama |
Genetic Variations and Drug Response in Gastroesophageal Reflux Disease (GERD): The Role of Pharmacogenomic Testing in Optimizing Proton Pump Inhibitor (PPI) Therapy |
DAY 3 Program
DAY 3
|
CET (Central European Time) |
Speaker |
Title |
|
8:30-8:40 |
Welcome from the session chair— |
|
| 8:40-9:10 |
Prof. Dr. Richard Sutton |
Syncope: New Approaches |
|
9:40-10:00 |
Dr. Mauro Feola |
Impact of drugs on cardiovascular mortality and sudden cardiac death |
|
10:00-10:15 |
Srdjan Nikolovski |
Comparison of Novel vs. Standard Myocardial Dysfunction Biomarkers and Analysis of Their Relation With Diastolic Dysfunction Grade in Kidney Transplant Recipients |
|
10:30-10:45 |
Lilia Sabantina and Patrizia Zimmermann Selected Speakers |
Optimizing Pattern Design and Standardizing Production for Abdominal Aortic Prostheses |
|
10:45-11:00 |
Dimitris Miliopoulos |
Left ventricular assist devices as a bridge to transplant strategy in a low organ donation environment: Single-center experiences |
Session S7. Oncology & Hematology
Session S4. AI & Telemedicine
|
CET (Central European Time) |
Speaker |
Title |
|
14:00-14:10 |
Welcome from the Session Chair (Session 7) — |
|
| 14:10-14:30 |
Dr. Helen Papadaki |
New insights in chronic idiopathic neutropenia
of adults
|
|
14:30-14:45 |
Maciej Dubaj |
Small molecules of great importance
|
|
14:45-15:00 |
Hamzah Adwan |
The Combination Therapy of Transarterial Chemoembolization and Microwave Ablation Leads to Better Survival for Liver Metastases from Colorectal Cancer: A Comparative Study |
|
15:00-15:15 |
Nikoleta Bizymi Selected Speaker |
Inflammageing: increase in polymorphonuclear myeloid-derived suppressor cells in aged healthy individuals |
|
15:15-15:30 |
BREAK | |
| 15:30-15:40 | Welcome from the Session Chairs (Session 4) — Dr. Carlos Escobar Cervantes and Assoc. Prof. Koroush Kabir |
|
| 15:40-16:00 |
Dr. Connie Y. Chang |
Challenges of Artificial Intelligence (AI) in radiology, with a Focus on Musculoskeletal Oncology |
| 16:00-16:15 | Sabrina Benghida Selected Speaker |
Transformative Impact of Telemedicine on Healthcare in South Korea: A Systematic Review |
| 16:15-16:30 | Hari K.C. Selected Speaker |
Integrating Artificial Intelligence in Telemedicine: Predicting Lung Cancer Disease and Decision Making |
Abstract Book
Poster Gallery
Recordings
Event Chairs
Internal Medicine Department, University Hospital Strasbourg, 67081 Strasbourg, France
Dr. Emmanuel Andrès is Editor-in-Chief of JCM since 2018. He is very active and knows the journal very well. He has a good reputation and has published more than 600 papers (H-index of 47 on Scopus). His research interests are drug-induced cytopenias, anemia, thrombocytopenia, neutropenia, cobalamin deficiency, vitamin B12 deficiency, telemedicine, chronic diseases, and chronic heart failure.
Kent Doi, M.D., Ph.D. is Professor of Medicine in the department of Emergency and Critical Care Medicine at The University of Tokyo, Japan. He received his M.D. and Ph.D. at the University of Tokyo followed by research nephrology training at NIH/NIDDK. At the University of Tokyo, Dr. Doi is currently a clinical and basic research investigator. His research interests include acute kidney injury, sepsis, and multiple organ failure. His research involves AKI biomarker, sepsis-induced AKI, and organ system network analysis in multiple organ failure. Dr. Doi is a council member of the Japanese Society of Intensive Care Medicine, Fellow of the Japanese Society of Internal Medicine (FJSIM), Councilor and Board-Certified Nephrologist of the Japanese Society of Nephrology, Board Certified Senior Member of the Japanese Society for Dialysis Therapy. Dr. Doi has published over 250 scientific articles and has delivered over 20 presentations at scientific meetings. He is an Associate Editor for multiple journals.
Session Chairs
Dr. Karl-Philip Rommel
Department of Cardiology, Heart Center Leipzig at University of Leipzig, 04289 Leipzig, Germany
https://tvt2023.crfconnect.com/faculty/Karl-Philipp-Rommel-12998
S1. Cardiology
Dr. Francisco Guillén Grima
1. Department of Preventive Medicine, Clinica Universidad de Navarra, University of Navarra, Spain; 2. Navarra Medical Research Institute (IdiSNA), Spain; 3. Center for Biomedical Research Network Epidemiology and Public Health, (CIBERESP), Spain; 4. Department of Health Sciences, Public University of Navarra, Spain
Dr. Francisco Guillen-Grima is a renowned Spanish physician and academic specializing in Preventive Medicine and Public Health. He earned his MD, PhD, and MBA from the University of Murcia and furthered his studies at Harvard University, obtaining an MPH and MSc in Epidemiology. His career includes roles such as Medical Officer in Murcia, Fulbright Scholar at Harvard, and Field Epidemiologist in Pamplona. Since 2005, he has been the Head of Preventive Medicine at the University of Navarra Clinic and a Full Professor at the Public University of Navarra. Dr. Guillen-Grima has also served as the director of several graduate programs and held advisory positions at ANECA. His leadership extended to serving as the Secretary of the Spanish Society of Preventive Medicine, Public Health, and Hygiene. His career is distinguished by his commitment to advancing public health education and policy.
S3. Epidemiology & Public Health
Assoc. Prof. Michele Roccella
Department of Psychology, Educational Science and Human Movement, University of Palermo, 90128 Palermo, Italy
https://www.unipa.it/persone/docenti/r/michele.roccella
S6. Mental Health
Dr. Alan Bernard Fleischer Jr.
Department of Dermatology, University of Cincinnati, 3230 Cincinnati, OH 45267, USA
Alan Fleischer is a professor and residency program director at the University of Cincinnati College of Medicine. In addition to clinical work, he has been involved as an investigator with hundreds of clinical trials and hundreds of health services research studies.
S8. Dermatology
Prof. Dr. Alex C. Spyropoulos
1. Institute of Health System Science, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY 11030, USA; 2. Anticoagulation and Clinical Thrombosis Services, Northwell Health at Lenox Hill Hospital, New York, NY 10075, USA; 3. The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY 11549, USA; 4. Elmezzi Graduate School of Molecular Medicine, Manhasset, NY 11030, USA
MD, FACP, FCCP, FRCPC
S7. Oncology & Hematology
Dr. Carlos Escobar Cervantes
Cardiology Department, University Hospital La Paz, 28046 Madrid, Spain
Cardiologist, coordinator of clinical cardiology and continuity of care with Primary Care, University Hospital La Paz, Madrid, Spain. Coordinator of automation of the vascular risk process of the Community of Madrid, Spain. Scientific coordinator of the DTX consortium. Past-member of the Executive Committee of the Investigation Agency of the Spanish Society of Cardiology. Past-president of the Clinical Cardiology group of the Spanish Society of Cardiology. Member of the European Society of Cardiology (ESC). Member of the Cardiovascular Pharmacology and Drug Therapy Working Group of ESC. Member of the Council of Cardio-Oncology Regular of ESC. Member of the Council of Stroke Regular of ESC. Member of the Spanish Society of Cardiology. Member of the International Lipid Expert Panel. Member of the working group of hypertension and cardiovascular disease of SEMERGEN (Spain). Referee of several national and international peer-review journals. Participation in several clinical trials and investigation projects in the fields of hypertension, heart failure, atrial fibrillation, acute coronary syndrome, pulmonary embolism and cardiometabolic disease. Over 400 papers published in national and international peer-review journals and over 50 chapters in Cardiology textbooks.
S4. AI & Telemedicine
Dr. Ariela Hoxha
Internal Medicine Unit, Thrombotic and Hemorrhagic Center, Department of Medicine, University of Padua, 35122 Padova, Italy
Dr. Ariela Hoxha, M.D., PhD, is a rheumatologist and senior consultant in Internal Medicine at the Center for Thrombotic and Hemorrhagic Diseases, Department of Medicine, University of Padua. Her clinical research focuses on systemic thrombo-inflammatory and autoimmune diseases, particularly with a focus on antiphospholipid antibody syndrome and connective tissue diseases. She is an ordinary member of national and international scientific societies and actively participates in national and international study groups on the study of systemic autoimmune diseases.
S5. Immunology
Assoc. Prof. Koroush Kabir
Department of Trauma Surgery, Orthopaedics & Sports Medicine, Helios University Hospital Wuppertal, 42283 Wuppertal, Germany
-
S4. AI & Telemedicine
Prof. Dr. Andrew Day
Department of Paediatrics, University of Otago Christchurch, Christchurch 8011, New Zealand
-
S2. Gastroenterology & Hepatopancreatobiliary Medicine
Event Committee
Department of Computer Science, Ostfalia University of Applied Sciences, Germany,
Biostatistics Group, Helmholtz Centre for Infection Research, Germany
exploratory data analysis, data visualisation, robust and computational statistics. He is a member of the editorial board of international journals like Data Mining, Modelling & Management (IJDMMM), Intelligent Data Analysis (IDA) and Evolving Systems (ES
Center for Adolescent Medicine and UNESCO Chair in Adolescent Health Care, First Department of Pediatrics, Medical School, National and Kapodistrian University of Athens, Greece,
Unit of Endocrinology, Diabetes and Metabolism, School of Medicine, National and Kapodistrian University of Athens, Aretaieion Hospital, Greece
immunologic pathways of stress, the role of gut microbiome. and the impact of stress on human body composition
Animal Facility and Animal Experimentation Unit, Biocruces Bizkaia Health Reseach Institute, Spain
Department of Radiology, Massachusetts General Hospital and Harvard Medical School, USA
School of Medicine, European University Cyprus, Nicosia
Department of Internal Medicine A, Division of Cardiology, Angiology, Nephrology and Intensive Medical Care, University Hospital Ruppin-Brandenburg (UKRB) of the Medical School of Brandenburg,
Medical Faculty, Martin Luther-University Halle-Wittenberg, Magdeburger Strasse 8, D-06112 Halle (Saale), Germany
Department of Public Health, School of Medicine, University of Patras, University Campus, Greece
Department of Paediatrics, University of Otago Christchurch, Christchurch 8011, New Zealand
Professor Day is an academic paediatric gastroenterologist based in Christchurch, New Zealand. Dr Day balances his clinical role with research endeavours that focus predominantly on aspects of IBD in children. Dr Day's research activities are supported by Cure Kids.
Hematology Unit and Bone Marrow Transplant, A.O.U. Policlinico “G. Rodolico—San Marco”, 95123 Catania, Italy
1. Department of Clinical Psychology and Psychobiology, University of Barcelona, 08035 Barcelona, Spain; 2. Institute of Neurosciences, University of Barcelona, 08035 Barcelona, Spain
BioImmuno Designs, Inc., Edmonton AB T5J 4P6, Canada
School of Medicine, University of Crete, 71500 Heraklion, Greece
Department of Public Health and Maternal & Child Health, Faculty of Medicine, Universidad Complutense de Madrid, 28040 Madrid, Spain
Department of Psychiatry, Medical University of Białystok, Wołodyjowskiego 2 Str., 15-272 Białystok, Poland
Department of Internal Medicine and Rheumatology, Spitalul Clinic Sfanta Maria, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania
Department of Haematology, Cancer Institute, University College of London, Paul O'Gorman Building, London WC1E 6BT, UK
Heart Failure, Transplant and Mechanical Circulatory Support Units, Onassis Cardiac Surgery Center, 17674 Athens, Greece
1. Hospital Universitario Virgen de las NIeves, 18014 Granada, Spain; 2. Instituto de Investigación Biosanitaria ibs.GRANADA, 18012 Granada, Spain
Department of Cardiac and Vascular Diseases, Institute of Cardiology, Jagiellonian University Medical College, św. Anny 12, 31-007
Krakow, Poland,
The St. John Paul II Hospital, Krakow 31-202, Poland
Department of Dermatology, Rambam Health Care Campus, Haifa 3109601, Israel
Faculty of Health Sciences, Kanazawa University, Kanazawa 920-0942, Ishikawa, Japan
Department of Surgery and Cancer, Imperial College Healthcare NHS Trust, London W12 0HS, UK
The Bristol Immunology and Allergy Centre, North Bristol NHS Trust, Bristol BS10 5NB, UK
Department of Medicine, Academy of Applied Medical and Social Sciences, Akademia Medycznych I Spolecznych Nauk Stosowanych (AMiSNS), 2
Lotnicza Street, 82-300 Elbląg, Poland,
Department of General Surgery and Surgical Oncology, “Saint Wojciech” Hospital, “Nicolaus Copernicus” Health Center, Jana
Pawła II 50, 80-462 Gdańsk, Poland
Dr. Luigi Marano is a Professor of Surgery at the Department of Medicine, Academy of Applied Medical and Social Sciences (AMiSNS) in Elbląg, Poland. He also serves as the supervisor of the Robotic and Advanced Minimally Invasive Surgical Program at the Department of General Surgery and Surgical Oncology, located at “Saint Wojciech” Hospital within the “Nicolaus Copernicus” Health Center in Gdańsk, Poland. In 2014, he attained the title of Specialist in General Surgery with top marks and honors. Throughout his academic career, Dr. Marano has demonstrated a keen interest in esophago-gastric surgery and oncological surgery, leading him to pursue a second-level University Master’s degree in “Oncological Digestive Surgery” at the Catholic University of the Sacred Heart in Rome in 2013. Since 2021, he has held the position of Permanent Associate Professor at the same department. Dr. Marano is a prolific author, with numerous scientific articles and book chapters published internationally, covering various topics within esophageal and stomach surgery, as well as oncological surgery. He currently serves as a member of the “Education and Training Committee-Upper-GI section” of the European Society of Surgical Oncology (ESSO). Additionally, from 2019 to 2020, he held the position of National Coordinator of the Italian Society of Oncological Surgery-Young (YSICO).
Department of Physiopathology and Transplantation, University of Milan, 20122 Milan, Italy,
Dermatology Unit, Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, 20122 Milan, Italy
Medicine and Oral Surgery Service and UNIPRO Research Unit (Director), University Institute of Health Sciences (IUCS-CESPU), 4585-116 Gandra, Portugal
Department of Internal Medicine, Faculty of Medicine, “Grigore T. Popa” University of Medicine and Pharmacy, 700115 Iasi, Romania
Keynote Speakers
Cancer Center Clinica Universidad de Navarra (CCUN), CIMA, IDISNA, 31008 Pamplona, Spain
Jesús San-Miguel is Professor of Medicine-Hematology , currently Senior Consultant and Strategic Advisor at the Cancer Center of Clinica Universidad de Navarra in Spain. For the past 10 years he has served at this institution as Director of Clinical and Translational Medicine. He was Director of the Hematology Department of the University Hospital of Salamanca in Spain, for more than 2 decades, also has served as Director of the Biomedical Research Institute of Salamanca and Vice Director of the Cancer Research Center. He was President of the International Myeloma Society from 2012 until 2019. Professor San-Miguel has published extensively (over 900 original papers, H-Index: 148 and >100.000 citations) and has made seminal contributions to myeloma cell biology in areas such as immunophenotyping, risk of progression from monoclonal gammopathy of undetermined significance or smouldering MM into active MM, and minimal residual disease and therapeutics, including studies for new antimyeloma drugs at the preclinical and clinical levels (5 drugs/combinations approved by FDA/EMA under his leadership) Dr San Miguel´s reputation has been recognized by more than 30 Research Awards and Honors, such as: the Waldenstrom Award, the Kyle Life Achievement Award, the EHA-Carreras Award, the Thomas H. Ham-Wasserman Lecture Award, the Michaelli Award, the KNAW Bob Pinedo Award, Premio Fundación Lilly, Premio Rey Jaime I and the Spanish National Prize of Medicine.
Department of Paediatrics, University of Otago Christchurch, Christchurch 8011, New Zealand
Professor Day is an academic paediatric gastroenterologist based in Christchurch, New Zealand. Dr Day balances his clinical role with research endeavours that focus predominantly on aspects of IBD in children. Dr Day's research activities are supported by Cure Kids.
Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 639798, Singapore
Epigenome-wide association study of skin physiology measures in a multi-ethnic Asian population
Marie Loh is an Assistant Professor in the Lee Kong Chian School of Medicine at Nanyang Technological University, Singapore, and a Senior Research Scientist at the Genome Institute of Singapore. She is also a Honorary Senior Lecturer at Imperial College London and Senior Research Scientist at the National Skin Centre, Singapore . Asst Prof Marie Loh is a molecular epidemiologist with a long-standing interest in the role of genetics and epigenetics underlying complex diseases, with a specific focus on ethnic differences in risk and outcome. Her current research focuses on combining population health with molecular phenotyping and laboratory-based approaches to advance knowledge and understanding in complex diseases such as atopic dermatitis.
National Heart and Lung Institute, Imperial College, Hammersmith Hospital Campus, Du Cane Road, London W12 0HS, UK
Syncope: New Approaches
MB BS DSc FRCP FACC FESC FAHA FHRS EHRA FBHRS Richard Sutton born Newport, UK, graduated King’s College Hospital Medical School 1964. He has been Consultant Cardiologist at Westminster, Chelsea-&-Westminster, Royal Brompton and St Mary’s Hospitals, London 1976-2011, Professor of Clinical Cardiology, Imperial College, London 2003; DSc London 1988; he has published >400 peer-reviewed papers on Pacing/Syncope/Cardiology and became Emeritus Professor and Honorary Consultant Cardiologist, Hammersmith Hospital, London in 2011. He has been President British Heart Rhythm Society (was BPEG) 1990-1995 (joint Founder), President European Working Group on Cardiac Pacing 1998-2000 (now EHRA) and President of Cardiology section, Royal Society of Medicine, London, UK (joint Founder); Editor-in-Chief Europace 1998-2006, now Founding Editor (2007-present). He won Lifetime Achievement Award Heart Rhythm Congress 2007, Pioneer in Cardiac Pacing & Electrophysiology, Heart Rhythm Society, 2016. He married Jeanne-Marie Arrighi in 2014 and lives in Monaco.
Medical Health Centre Frauenfeld, Frauenfeld, Switzerland
An up-date of Lichen sclerosus
I am a Consultant Dermatologist based in Germany and Switzerland. I studied medicine at Ulm University & Muenster University in Germany and have previously practiced dermatology in academic centres in Oxford, UK and Amsterdam, NL. I have special interest in vulval skin disease, pregnancy associated skin disease and blistering skin conditions. I have a strong research interest and my work has contributed towards the production of more than 100 peer reviewed scientific articles, national/international clinical guidelines, and patients’ information leaflets. Together with more than 20 co-authors I have edited a prize-winning book on vulval diseases. I work with the Cochrane skin group to deliver systematic reviews and sit on the oversight committees of clinical trials and I am the senior author of the European S3 guideline on Lichen sclerosus, updated in 2023. I am committed to excellence in clinical dermatology. I am a member of the Lichen Sclerosus PSP and the steering group to develop Core Outcome Sets (COS) for LS.
Department of Psychiatry, Medical University of Białystok, Wołodyjowskiego 2 Str., 15-272 Białystok, Poland
Legal and illegal high
Graduate of the Medical University of Bialystok. Specialist in Psychiatry. Currently, he is the head of the Medical University Clinic in Białystok and the President of the Podlasy Branch of the Polish Psychiatric Association.
Invited Speakers
Helen Papadaki is a Professor of Haematology at the School of Medicine, University of Crete (UoC), Greece. She is Head of the Department of Haematology, Cell Therapy Unit and the Public Cord Blood Bank of the University Hospital of Heraklion, Crete, and Head of the Haemopoiesis Research Laboratory, UoC. Dr. Papadaki received her MD from the UoAthens with honours and her PhD from the UoC. She has been trained in Internal Medicine and Haematology at the UoC and has been post-doc researcher (EMBO fellowship) in Saint George’s Medical School, London, UK, visiting scientist at the Institute for Cancer Studies, Birmingham, UK and visiting physician at the Department of Haematology, University of Washington, Seattle, USA. Dr Papadaki has been appointed Deputy Rector of the UoC (2013-2015), has been elected as European Haematology Association (EHA) Board Member (2016 – 2020), she is now co-chairing the EHA Community and Stakeholder Committee and is a member of the EHA Good Governance Committee. She is the co-chair of the EHA Scientific Working Group on Granulocyte and Constitutional Marrow Failure Syndromes, external advisory board member of the Severe Chronic Neutropenia International Registry (SCNIR). Dr Papadaki’s main field of interest is Neutropenia, Bone Marrow Failure Syndromes and Umbilical Cord Blood applications. She had been the PI in a number of national and international Projects, she has more than 200 publications and more than 7000 citations. She has been awarded by 25 Awards for best abstract or full paper in the Hellenic Haematology Association and has received the Health Care Greek Award for the category “Research in Hospital” in 2021 and 2023.
Department of Health Policy and Management, School of Public Health, Faculty of Health Sciences, Ben Gurion University of the Negev (BGU), Beer Sheva 84105, Israel
Prof. Nadav Davidovitch is an epidemiologist and public health physician and Head of Ben-Gurion University of the Negev’s School of Public Health. In the past, he has served as Chair of the Association of Public Health Physicians in Israel and the cabinet of the “Magen Israel” program (a national program for fighting the coronavirus). He is currently a member of various international committees including Chair of ASPHER Task Force on Public Health Emergencies. Prof. Davidovitch has authored a great many articles and books on the subject of public health, health policy, health economics, health systems management, ethics and sociology of health. Since the outbreak of COVID-19 in Israel, he has been involved in research and the formulation of health policy and has advised various agencies in Israel and abroad on the need to make structural changes in the health system, with an emphasis on social issues and addressing health gaps.
Department of Medical Sciences, University of Turin, 10126 Turin, Italy
: Graduated in Medicine and Surgery in 2011, specialized in Gastroenterology in 2017 at University of Turin, Doctoral degree in Bioengineering and Medical-Surgical Science in 2022 (University of Turin - Polytechnic). Degree in Telecommunication Engineering in 2005 at the Polytechnic University of Turin. Associate professor at the Department of Medical Sciences and gastroenterologist consultant, head of IBD clinic at "A.O.U. Città della Salute e della Scienza di Torino" - "Molinette" hospital.
Cardiology Division Ospedale Regina Montis Regalis, Strada del Rocchetto 99, 12084 Mondovi, Italy
Cardiac sudden death in heart failure patients
Clinical Cardiologist; Head of the Cardiology Division in Hospital Regina MOntis Regalis Mondovi' ITALY; field of interest: CV imaging; heart Failure. Authors of >100 manuscripts indexed in PubMed.
Division of Musculoskeletal Imaging and Intervention, Department of Radiology, Massachusetts General Hospital, Boston, MA 02114, USA,
Harvard Medical School, Cambridge, MA 02115, USA
Challenges of Artificial Intelligence (AI) in Radiology, With a Focus on Musculoskeletal Oncology
Dr. Chang graduated from MIT and Cornell Medical School, after which she completed her radiology training at Massachusetts General Hospital of Harvard Medical School. She works in the field of Musculoskeletal Imaging in Intervention, and has published more than 100 manuscripts and given more than 100 talks. Her research interests focus on Tumor, Infection and Intervention, including AI applications. To learn more about her and her work, please go to https://cychang.mgh.harvard.edu/
Registration
Registration for ECCM 2024 will be free of charge! The registration includes attendance at all conference sessions.
If you are registering several people under the same registration, please do not use the same email address for each person, but their individual university email addresses. Thank you for your understanding.
Please note that the submission and registration are two separate parts. Only scholars who registered can receive a link to access the conference live streaming. The deadline for registration is 8 November 2024.
Instructions for Authors
Deadline for abstract submission: 16 August 2024
Announcement of oral and poster abstract results: 6 September 2024; You will be notified of the acceptance of an oral/poster presentation in a separate email.
Abstract Submission
1. Abstract submissions should be completed online by registering with www.sciforum.net and using the "Submit Abstract" function once logged into the system. No physical submission is necessary.
2. The abstract should include an introduction, methods, results, and conclusion sections, and be about 200–300 words in length.
3. All abstracts should be submitted and presented in clear, publication-ready English with accurate grammar and spelling.
4. You may submit multiple abstracts. However, only one abstract will be selected for oral presentation.
5. All abstracts accepted for presentation will be collected in a book of abstracts, which will be published on the website after the conference.
Detailed Requirements:
1. The submitting author must ensure that all co-authors are aware of the contents of the abstract.
2. Please select only one presenter for each submission. If you would like to change the presenter after submission, please email us accordingly.
Note: We only accept live presentations.
The slot for the oral presentation is 15 minutes. We recommend a 12-minute presentation, leaving about 3 minutes for a Q&A session.
Authors are encouraged to prepare a presentation in PowerPoint or similar software, to be displayed online along with the abstract. Slides, if available, will be displayed directly on the website using the proprietary slide viewer at Sciforum.net. Slides can be prepared in exactly the same way as for any traditional conference where research results are presented. Slides should be converted to PDF format prior to submission so that they can be converted for online display.
Poster Gallery
permanently exhibited online in the Poster Gallery.
Potential Conflicts of Interest
It is the authors' responsibility to identify and declare any personal circumstances or interests that may be perceived as inappropriately influencing the representation or interpretation of clinical research. If there is no conflict, please state "The authors declare no conflicts of interest." This should be conveyed in a separate "Conflict of Interest" statement preceding the "Acknowledgments" and "References" sections at the end of the manuscript. Any financial support for the study must be fully disclosed in the "Acknowledgments" section.
MDPI, the publisher of the Sciforum.net platform, is an open access publisher. We believe authors should retain the copyright to their scholarly works. Hence, by submitting an abstract to this conference, you retain the copyright to the work, but you grant MDPI the non-exclusive right to publish this abstract online on the Sciforum.net platform. This means you can easily submit your full paper (with the abstract) to any scientific journal at a later stage and transfer the copyright to its publisher if required.
Publication Opportunities
Participants in this conference are cordially invited to contribute a research article to the Special Issue, published in Journal of Clinical Medicine (ISSN: 2077-0383, Impact Factor: 3.0), with a 20% discount on the publication fee. Please note that if you have IOAP/association discounts, conference discounts will be combined with IOAP/association discounts. Details of the special issue will be announced here later. All submitted papers will undergo MDPI’s standard peer-review procedure. The abstracts should be cited and noted on the first page of the paper.
- Proceeding Paper Publication
All accepted abstracts will be published in the conference report of ECCM2024 in Medical Sciences Forum (ISSN: 2673-9992); if you wish to publish an extended proceeding paper (4-8 pages), please submit it to the same journal after the conference.
Authors are asked to disclose that it is a proceeding paper of the ECCM 2024 conference paper in their cover letter. Carefully read the rules outlined in the 'Instructions for Authors' on the journal’s website and ensure that your submission adheres to these guidelines.
Proceedings paper submission deadline: 31 December 2024.
- Title.
- Full author names.
- Affiliations (including full postal address) and authors' e-mail addresses.
- Abstract.
- Keywords.
- Introduction.
- Methods.
- Results and Discussion.
- Conclusions.
- Acknowledgements.
- References.
List of accepted submissions (76)
| Id | Title | Authors | |
|---|---|---|---|
| sciforum-105051 | Bergenia crassifolia extract-loaded nanogel to untangle the web of psoriasis: Characterization and In Vivo evaluation in an IMQ-induced rat model | , |
Show Abstract |
| sciforum-105067 | In vitro studies on the use of Extremely Low Frequency (ELF) Electromagnetic Fields as a meansof increasing the effectiveness of anticancer drugs |
,
,
Wojciech Dziewiszek ,
,
,
Adam Szeląg
|
Show Abstract |
| sciforum-104936 | EphB4 knockdown inhibits the growth and epithelial–mesenchymal transition of gastric cancer cells and triggers death via the PI3K/AKT pathway. | , |
Show Abstract |
| sciforum-100925 | Is exercise fun? Virtual-reality boxing versus traditional cardio to improve in-task valance and post-exercise enjoyment. |
,
Mervin Jijika ,
Scott Anderson ,
|
Show Abstract |
| sciforum-100995 | Meeting the health needs of people fleeing Ukraine: Evidence from the Polish Nationwide General Hospital Morbidity Study, 2022–2023 |
,
Anna Poznańska ,
,
,
,
,
Aneta Nitsch-Osuch
|
Show Abstract |
Event Awards
To acknowledge the support of the conference's esteemed authors and recognize their outstanding scientific accomplishments, we are pleased to announce that the conference will provide 6 awards including Best Oral Presentation Award and Best Poster Award.
The Awards
Number of Awards Available: 6
The Best Oral Presentation Award is given to the submission judged to make the most significant oral contribution to the conference.
The Best Poster Award is given to the submission judged to make the most significant and interesting poster for the conference.
There will be six winners selected for this award. The winner will receive a certificate and 200 CHF each.
Sponsors and Partners
For information regarding sponsorship and exhibition opportunities, please click here.
Organizers
Media Partners
Conference Secretariat
Ms. Niya Wu
Ms. Ioana Vintila
For inquiries regarding submissions and sponsorship opportunities, please feel free to contact us.
Email: eccm2024@mdpi.com
